Loading

Search

:

Silkworm-Based Drug Planned

  • Category:Other
FUKUOKA (Jiji Press) — A company was founded in April to make pharmaceutical materials using silkworms.

The company, based in Fukuoka, is called Kaico, which means silkworm in Japanese. It was established using financial assistance from Kyushu University.

Kaico plans to make raw materials for regenerative medicine reagents using proteins extracted from silkworms, starting as early as this summer.
In the future, the start-up aims to develop raw materials for diagnostic agents for animal ailments and vaccines for human use.

Kaico will use technological achievements made by the university, which has a history of more than a century of silkworm research. The university raises 150,000 silkworms of about 500 kinds, one of the world’s largest stocks.

The university has been designated as a core silkworm research base in the government’s National BioResource Project, a framework for systematic collection and preservation of bioresources.

Kaico will utilize the findings of research by Takahiro Kusakabe, professor of agricultural bioresource sciences at the university, to extract proteins from silkworms.
 
 

Comment(s) Write comment

Trackback (You need to login.)